AzTrials
AzTrials

Abdominal AneurysmNCT07577128

Familial Risk of AAA in Sweden

An observational study of Abdominal Aneurysm and Aortic Aneurysm, run by Karolinska University Hospital at 1 site in Sweden.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The aim is to study the prevalence of abdominal aortic aneurysm in first degree relatives and the risk to develop AAA in individuals with heredity for AAA compared with the population ( without heredity for AAA).The study i based on national registers in Sweden with high coverage and capacity of linkage between… Read more about this study

Who is it for?
Ages 45 years and older
How many people
900,000 participants
Where
1 siteSweden
Study dates
Jan 2010to 31 Dec 2028
How long will I take part?
1 Week
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Individuals with the diagnose AAA or the cause of death AAA in Sweden 2010-2024. The first-degree relatives have been identified through the Swedish multigeneration register and then a register based identifiaction if having AAA or not. All men and female over 45 years old are included.

Who may be able to join

  • -

Who cannot join

  • younger than 45 years.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska Institutet

    Stockholm

Other trials in Sweden

About this study

Official title: Familial Risk of Abdominal Aortic Aneurysm in Sweden

The aim is to study the prevalence of abdominal aortic aneurysm in first degree relatives and the risk to develop AAA in individuals with heredity for AAA compared with the population ( without heredity for AAA).The study i based on national registers in Sweden with high coverage and capacity of linkage between different registers.

Read the detailed description

The study is designed as a retrospective, descriptive case-control population based national study. By using national registers, eligible patients diagnosed with AAA during the time period 2010-2024 will be identified, ( treated and untreated). The time period includes when screening was established in Sweden resulting in a large cohort of diagnosed men. Hence, individuals with diagnosed with AAA will be identified through registers at the National health and bord of welfare (Cause of death register, National patient register, Discharge register). Matched controls by sex, age (+/- 1 year), region and income (low,medium, high) will be identified in a ratio of x 4 from Statistic Sweden. These individuals will then be linked to the multigeneration register for identification of their first degree relatoves (FDR). In the finalstep, the FDR will be linked to NBHW register in order to evaluate if the individuals are diagnosed with AAA (rAAA or iAAA) or not. Socioeconomic data and comorbidity will also be collected for FDR, indexperson and matched controls.

Overall aim: To improve the understanding of the hereditary patterns for aortic disease, with specific consideration of regional differences and sex.

Hypothesis: An increased risk to develop any aortic disease will be detected in persons with one or more first-degree-relatives diagnosed with an aortic disease, which will remain although standard adjustments will be considered (age, sex, comorbidity,socioeconomic status).

Aims: 1)To describe the risk for female and male first-degree relatives (FDR) to female and male persons diagnosed with AAA (index persons) to develop a diagnosed AAA,compared to the population. 2) Identification of possible predictive associated risk factors (modifiable/non-modifiable, protective or negative) age, sex, region, other cardiovascular diseases,comorbidities, several FDRs, socioeconomic situation, multilevel aortic disease thatinfluences the hereditary risk.3)To describe the distribution of female and male first-degree relatives (FDR) to female and male persons diagnosed with AAA (index persons) to be diagnosed with a ruptured AAA rather than intact AAA, compared to the population.

Keywords
Abdominal aortic aneurysm, Heredity, Screening, Familial risk
Medical subject headings
Aortic Aneurysm, Abdominal, Aortic Aneurysm

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07577128
Study groupRoleWhat they receive
Index casesIndividuals with diagnosed abdominal aortic aneurysm during 2010- 2024
First-degree relatives to index casesFirst- degree relatives to index cases with AAA. Siblings, Parents, Children identified through the Multigeneration register.
Index controlsControl population to index cases based on sex, age, region and income.
First-degree relatives of controlsFirst-degree relatives of the control population (index controls). Individuals without familial AAA.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Familial risk of Abdominal Aortic Aneurysm in first-degree relatives compared with the population.

    To describe the risk for female and male first-degree relatives (FDR) to female and male persons diagnosed with AAA (index persons) to develop a diagnosed AAA, compared to the population.

    Measured: Through study completion, data spanning 1952 to 2024

Secondary outcomes (1)
  1. Heredity as a risk factor for AAA

    Hypothesis: Although factors as age, male sex and cardiovascular disease increases the risk for AAA, heredity will remain a risk factor for development of AAA after adjustment.

    1. Identification of possible predictive associated risk factors (modifiable/non- modifiable, protective or negative) age, sex, region, other cardiovascular diseases, comorbidities, several FDRs, socioeconomic situation, multilevel aortic disease that influences the hereditary risk.

    Measured: At time of AAA diagnosis, cases diagnosed between 2010 and 2024.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2026
  2. Study startJan 2010
  3. Primary completionJun 2026 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
900,000 participants (estimated)
Target duration
1 Week
IDs, dates and publications
ClinicalTrials.gov ID
NCT07577128
Sponsor's protocol ID
Karolinska Institutet
Status last verified
May 2026
First submitted
15 Apr 2026
Last updated
11 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared with external parties due to Swedish legislation on personal data protection (GDPR) and restrictions governing access to national health register data. Data will only be accessible to the research team named in the ethical approval

Questions about this trial

What is this clinical trial studying?

An observational study of Abdominal Aneurysm and Aortic Aneurysm, run by Karolinska University Hospital at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 11 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Familial risk of Abdominal Aortic Aneurysm in first-degree relatives compared with the population. (time frame: Through study completion, data spanning 1952 to 2024). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in